• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡托普利代谢物卡托普利-L-半胱氨酸在大鼠和犬体内的代谢

Metabolism of captopril-L-cysteine, a captopril metabolite, in rats and dogs.

作者信息

Kripalani K J, Dean A V, Migdalof B H

出版信息

Xenobiotica. 1983 Dec;13(12):701-5. doi: 10.3109/00498258309052231.

DOI:10.3109/00498258309052231
PMID:6372264
Abstract

The metabolism of [14C]captopril-L-cysteine was studied in spontaneously hypertensive rats and pure-bred beagles after a single i.v. dose (4 mg/kg). During the first 24 h, concn. of total radioactivity in blood were similar in both species. Captopril was found in small amounts in the blood of both species. In rats, captopril, bound covalently but reversibly to plasma proteins (CP-PR), was the major component in blood (70%), whereas captopril-L-cysteine was a minor component (23%) of the total radioactivity. In dog blood, CP-PR constituted a smaller fraction (45%) of the total radioactivity than in the rat and captopril-L-cysteine was the major component (53%). In 72 h, 89-91% of the dose was excreted in the urine of rats and dogs. Captopril-L-cysteine accounted for 7% (rat) and 68% (dog) of the radioactivity in urine; captopril accounted for 75% (rat) and 7% (dog). Other metabolites were present in the urine of both species. The greater net conversion of captopril-L-cysteine to CP-PR and to captopril in rats helps explain why captopril-L-cysteine is excreted in urine as a major metabolite of captopril in dogs but only a minor one in rats.

摘要

在自发性高血压大鼠和纯种比格犬静脉注射单次剂量(4毫克/千克)[¹⁴C]卡托普利 - L - 半胱氨酸后,对其代谢情况进行了研究。在最初的24小时内,两种动物血液中总放射性浓度相似。在两种动物的血液中均发现了少量卡托普利。在大鼠中,与血浆蛋白共价结合但可逆结合的卡托普利(CP - PR)是血液中的主要成分(70%),而卡托普利 - L - 半胱氨酸是总放射性的次要成分(23%)。在犬类血液中,CP - PR在总放射性中所占比例(45%)低于大鼠,且卡托普利 - L - 半胱氨酸是主要成分(53%)。在72小时内,89 - 91%的剂量经大鼠和犬的尿液排出。卡托普利 - L - 半胱氨酸在大鼠尿液放射性中占7%,在犬尿液中占68%;卡托普利在大鼠尿液中占75%,在犬尿液中占7%。两种动物的尿液中均存在其他代谢产物。卡托普利 - L - 半胱氨酸在大鼠体内向CP - PR和卡托普利的净转化率更高,这有助于解释为什么卡托普利 - L - 半胱氨酸在犬尿液中作为卡托普利的主要代谢产物排出,而在大鼠尿液中只是次要代谢产物。

相似文献

1
Metabolism of captopril-L-cysteine, a captopril metabolite, in rats and dogs.卡托普利代谢物卡托普利-L-半胱氨酸在大鼠和犬体内的代谢
Xenobiotica. 1983 Dec;13(12):701-5. doi: 10.3109/00498258309052231.
2
Drug protein conjugates--I. A study of the covalent binding of [14C]captopril to plasma proteins in the rat.
Biochem Pharmacol. 1982 May 1;31(9):1755-60. doi: 10.1016/0006-2952(82)90680-3.
3
Drug-protein conjugates--IV. The effect of acute renal failure on the disposition of [14C]captopril in the rat.
Biochem Pharmacol. 1983 Sep 1;32(17):2467-72. doi: 10.1016/0006-2952(83)90003-5.
4
Captopril: pharmacology, metabolism and disposition.卡托普利:药理学、代谢与处置
Drug Metab Rev. 1984;15(4):841-69. doi: 10.3109/03602538409041080.
5
Disposition and metabolism of the novel antihypertensive agent alacepril in rats.
Arzneimittelforschung. 1986;36(1):40-6.
6
Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.新型认知增强剂NS-105的药代动力学。首次通讯:单次给予14C-NS-105后在大鼠、犬和猴体内的吸收、代谢及排泄情况
Arzneimittelforschung. 1999 Nov;49(11):881-90. doi: 10.1055/s-0031-1300521.
7
Metabolism of labetalol by animals and man.拉贝洛尔在动物和人体内的代谢。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
8
The metabolism of the anti-inflammatory drug eterylate in rat, dog and man.
Xenobiotica. 1983 Dec;13(12):731-42. doi: 10.3109/00498258309052235.
9
The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans.
Xenobiotica. 1980 Dec;10(12):873-88. doi: 10.3109/00498258009033821.
10
Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.去乙酰阿拉普利蛋白结合物的代谢及其对肾性高血压大鼠血管紧张素转换酶的影响。
Arzneimittelforschung. 1986;36(1):52-4.

引用本文的文献

1
Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.卡托普利在健康受试者和心血管疾病患者中的药代动力学。
Clin Pharmacokinet. 1988 Apr;14(4):241-59. doi: 10.2165/00003088-198814040-00002.